(Q35101150)

6 August 2017

1 reference

title

British Society for Medical Mycology proposed standards of care for patients with invasive fungal infections (English)

1 reference

invasive fungal infections

6 August 2017

0 references

1 reference

1

1 reference

6 August 2017

author name string

Christopher C Kibbler

series ordinal

2

1 reference

6 August 2017

Rosemary A Barnes

series ordinal

3

1 reference

6 August 2017

British Society for Medical Mycology

series ordinal

4

1 reference

6 August 2017

publication date

1 April 2003

1 reference

Lancet Infectious Diseases

6 August 2017

published in

1 reference

6 August 2017

volume

3

1 reference

6 August 2017

issue

4

1 reference

6 August 2017

page(s)

230-240

1 reference

Aspergillosis and other systemic mycoses. The growing problem

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900580-2

7 January 2021

Trends in the postmortem epidemiology of invasive fungal infections at a university hospital

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900580-2

7 January 2021

Epidemiology of visceral mycoses: analysis of data in annual of the pathological autopsy cases in Japan

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900580-2

7 January 2021

Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900580-2

7 January 2021

Practice guidelines for diseases caused by Aspergillus. Infectious Diseases Society of America

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900580-2

7 January 2021

Increase inCandida kruseiInfection among Patients with Bone Marrow Transplantation and Neutropenia Treated Prophylactically with Fluconazole

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900580-2

7 January 2021

Correlation between in vitro and in vivo activity of antifungal agents against Candida species

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900580-2

7 January 2021

Azole resistance in Candida

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900580-2

7 January 2021

In-vitro testing of susceptibility to amphotericin B is a reliable predictor of clinical outcome in invasive aspergillosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900580-2

7 January 2021

In vitro amphotericin B resistance in clinical isolates of Aspergillus terreus, with a head-to-head comparison to voriconazole.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900580-2

7 January 2021

Lack of correlation of in vitro amphotericin B susceptibility testing with outcome in a murine model of Aspergillus infection.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900580-2

7 January 2021

Clinical, cellular, and molecular factors that contribute to antifungal drug resistance.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900580-2

7 January 2021

Treatment of Absidia corymbifera infection in mice with amphotericin B and itraconazole

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900580-2

7 January 2021

Candida parapsilosis bloodstream infections in neonatal intensive care unit patients: epidemiologic and laboratory confirmation of a common source outbreak

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900580-2

7 January 2021

An outbreak of Candida parapsilosis prosthetic valve endocarditis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900580-2

7 January 2021

Outbreak of Candida parapsilosis fungemia in neonatal intensive care units: clinical implications and genotyping analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900580-2

7 January 2021

Molecular typing for investigating an outbreak of Candida krusei

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900580-2

7 January 2021

Nosocomial cluster of Candida lipolytica fungemia in pediatric patients

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900580-2

7 January 2021

Pichia anomala outbreak in a nursery: exogenous source?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900580-2

7 January 2021

Candida tropicalis and Candida albicans fungemia in children with leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900580-2

7 January 2021

Association of fungal infection and increased mortality in liver transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900580-2

7 January 2021

The impact of culture isolation of Aspergillus species: a hospital-based survey of aspergillosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900580-2

7 January 2021

Prospective multicenter surveillance study of funguria in hospitalized patients. The National Institute for Allergy and Infectious Diseases (NIAID) Mycoses Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900580-2

7 January 2021

Lysis-centrifugation blood cultures in the detection of tissue-proven invasive candidiasis. Disseminated versus single-organ infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900580-2

7 January 2021

Collection, transport, and processing of blood cultures.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900580-2

7 January 2021

Evaluation of BACTEC MYCO/F Lytic medium for recovery of mycobacteria, fungi, and bacteria from blood

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900580-2

7 January 2021

The role of bronchoalveolar lavage in the diagnosis of invasive pulmonary aspergillosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900580-2

7 January 2021

The value of bronchoalveolar lavage and bronchial washings in the diagnosis of invasive pulmonary aspergillosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900580-2

7 January 2021

Aspergillus in cytology specimens: a review of 45 specimens from 36 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900580-2

7 January 2021

Stage-specific manifestation of mold infections in bone marrow transplant recipients: risk factors and clinical significance of positive concentrated smears.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900580-2

7 January 2021

The Role of Bronchoalveolar Lavage in the Microbiological Diagnosis of Pneumonia in Patients with Haematological Malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900580-2

7 January 2021

Evaluation of Calcofluor staining in the diagnosis of fungal corneal ulcer

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900580-2

7 January 2021

Diagnosis of pulmonary aspergillosis using optical brighteners

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900580-2

7 January 2021

Economical microscope configuration for direct mycological examination with fluorescence in dermatology

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900580-2

7 January 2021

Pulmonary mucormycosis: results of medical and surgical therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900580-2

7 January 2021

New insights into transmission, diagnosis, and drug treatment of Pneumocystis carinii pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900580-2

7 January 2021

The use of respiratory-tract cultures in the diagnosis of invasive pulmonary aspergillosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900580-2

7 January 2021

Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900580-2

7 January 2021

Aspergillus nidulans Infection in Chronic Granulomatous Disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900580-2

7 January 2021

Antifungal drug resistance in Aspergillus

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900580-2

7 January 2021

Performance of cryptococcus antigen latex agglutination kits on serum and cerebrospinal fluid specimens of AIDS patients before and after pronase treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900580-2

7 January 2021

Fungal Meningitis Manifesting as Hydrocephalus

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900580-2

7 January 2021

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900580-2

1 reference

7 January 2021

Practice guidelines for the management of patients with histoplasmosis. Infectious Diseases Society of America

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900580-2

7 January 2021

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900580-2

1 reference

7 January 2021

A simple method for detecting subcutaneous phaeohyphomycosis with light-colored fungi. A study of eight cases.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900580-2

7 January 2021

Histopathology of experimental Aspergillus fumigatus keratitis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900580-2

7 January 2021

Imaging in the diagnosis of infections in immunocompromised patients

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900580-2

7 January 2021

Invasive pulmonary aspergillosis in acute leukemia: characteristic findings on CT, the CT halo sign, and the role of CT in early diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900580-2

7 January 2021

Fungal pulmonary infections after bone marrow transplantation: evaluation with radiography and CT.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900580-2

7 January 2021

Pulmonary nodules and the CT halo sign

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900580-2

7 January 2021

Invasive pulmonary aspergillosis. MRI, CT, and plain radiographic findings and their contribution for early diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900580-2

7 January 2021

Increasing volume and changing characteristics of invasive pulmonary aspergillosis on sequential thoracic computed tomography scans in patients with neutropenia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900580-2

7 January 2021

Pneumonia in febrile neutropenic patients and in bone marrow and blood stem-cell transplant recipients: use of high-resolution computed tomography.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900580-2

7 January 2021

Management of invasive pulmonary aspergillosis in hematology patients: a review of 87 consecutive cases at a single institution

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900580-2

7 January 2021

An EORTC multicentre prospective survey of invasive aspergillosis in haematological patients: diagnosis and therapeutic outcome. EORTC Invasive Fungal Infections Cooperative Group

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900580-2

7 January 2021

Fatal haemoptysis in pulmonary filamentous mycosis: an underevaluated cause of death in patients with acute leukaemia in haematological complete remission. A retrospective study and review of the literature. Gimema Infection Program (Gruppo Italiano

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900580-2

7 January 2021

Aspergillosis case-fatality rate: systematic review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900580-2

7 January 2021

Progress in the diagnosis and management of aspergillosis in bone marrow transplantation: 13 years' experience.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900580-2

7 January 2021

Risk factors for invasive fungal infections complicating orthotopic liver transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900580-2

7 January 2021

Aspergillus airway colonization and invasive disease after lung transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900580-2

7 January 2021

Brain abscess following marrow transplantation: experience at the Fred Hutchinson Cancer Research Center, 1984-1992.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900580-2

7 January 2021

Localization of aspergillosis to the central nervous system among patients with acute leukemia: report of 14 cases. Gruppo Italiano Malattie Ematologiche dell'Adulto Infection Program.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900580-2

7 January 2021

Therapeutic outcome in invasive aspergillosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900580-2

7 January 2021

Treatment of cerebral Aspergillosis with itraconazole: do high doses improve the prognosis?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900580-2

7 January 2021

Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900580-2

7 January 2021

Candidemia in children with central venous catheters: role of catheter removal and amphotericin B therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900580-2

7 January 2021

Intravascular catheter exchange and duration of candidemia. NIAID Mycoses Study Group and the Candidemia Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900580-2

7 January 2021

Candidemia in non-neutropenic critically ill patients: analysis of prognostic factors and assessment of systemic antifungal therapy. Study Group of Fungal Infection in the ICU

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900580-2

7 January 2021

A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. Candidemia Study Group and the National Institute

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900580-2

7 January 2021

Management of invasive candidal infections: results of a prospective, randomized, multicenter study of fluconazole versus amphotericin B and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900580-2

7 January 2021

Multicenter randomized trial of fluconazole versus amphotericin B for treatment of candidemia in non-neutropenic patients. Canadian Candidemia Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900580-2

7 January 2021

Influence of continuous veno-venous haemodiafiltration and continuous veno-venous haemofiltration on the pharmacokinetics of fluconazole

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900580-2

7 January 2021

Treatment of Candida albicans fungaemia with fluconazole

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900580-2

7 January 2021

Fluconazole versus amphotericin B in the treatment of hematogenous candidiasis: a matched cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900580-2

7 January 2021

International Conference for the Development of a Consensus on the Management and Prevention of Severe Candidal Infections

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900580-2

7 January 2021

Practice guidelines for the treatment of candidiasis. Infectious Diseases Society of America

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900580-2

7 January 2021

The safety and efficacy of amphotericin B colloidal dispersion in the treatment of invasive mycoses

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900580-2

7 January 2021

Retrospective analysis of the dosage of amphotericin B lipid complex for the treatment of invasive fungal infections

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900580-2

7 January 2021

Epidemiology, diagnosis and treatment of systemic Candida infection in surgical patients under intensive care.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900580-2

7 January 2021

Treatment of Fungal Infections With Flucytosine

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900580-2

7 January 2021

Flucytosine in the management of genitourinary candidiasis: 5 years of experience

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900580-2

7 January 2021

Management of neonatal candidiasis. Neonatal Candidiasis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900580-2

7 January 2021

Comparison of caspofungin and amphotericin B for invasive candidiasis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900580-2

7 January 2021

Aspergillus species isolated from clinical specimens: suggested clinical and microbiological criteria to determine significance

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900580-2

7 January 2021

A Comparison of Amphotericin B Alone and Combined with Flucytosine in the Treatment of Cryptoccal Meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900580-2

7 January 2021

Fluconazole compared with amphotericin B plus flucytosine for cryptococcal meningitis in AIDS. A randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900580-2

7 January 2021

Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. The NIAID Mycoses Study Group and the AIDS Clinical Trials Group

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900580-2

7 January 2021

Itraconazole compared with amphotericin B plus flucytosine in AIDS patients with cryptococcal meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900580-2

7 January 2021

Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900580-2

7 January 2021

A comparison of itraconazole versus fluconazole as maintenance therapy for AIDS-associated cryptococcal meningitis. National Institute of Allergy and Infectious Diseases Mycoses Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900580-2

7 January 2021

Liposomal amphotericin B (AmBisome) compared with amphotericin B both followed by oral fluconazole in the treatment of AIDS-associated cryptococcal meningitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900580-2

7 January 2021

Comparative efficacy and distribution of lipid formulations of amphotericin B in experimental Candida albicans infection of the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900580-2

7 January 2021

10.1016/S1473-3099(03)00580-2

Identifiers

DOI

1 reference

6 August 2017

1 reference